4841
|
|
|
Forkhead box P4 |
hFKHLA |
Alzheimer disease, Breast cancer, Cancer, Colorectal cancer, Neurodevelopmental disorder, Epiphyseal dysplasia, Estrogen-receptor negative breast cancer, Global developmental delay, Hearing impairment, Laryngeal hypoplasia, Lung cancer, Non-specific syndromic intellectual disability, Open angle glaucoma, Ovarian cancer, Ovarian serous carcinoma, Prostate cancer, Prostatic neoplasms, Hearing loss, Squamous cell carcinoma, Ventricular septal defect, Vesicoureteral refluxView all (6 more) |
4842
|
|
|
Forkhead box Q1 |
HFH1 |
|
4843
|
|
|
Forkhead box R1 |
DLNB13, FOXN5 |
|
4844
|
|
|
FAD dependent oxidoreductase domain containing 1 |
FP634, H17, MC1DN19 |
|
4845
|
|
|
Folylpolyglutamate synthase |
- |
|
4846
|
|
|
Fucose-1-phosphate guanylyltransferase |
GFPP |
|
4847
|
|
|
FPGT-TNNI3K readthrough |
CARK, TNNI3K |
Arrhythmogenic right ventricular cardiomyopathy, Atrial fibrillation, Attention deficit hyperactivity disorder, Bronchial disease, Cardiac conduction disease, Dilated cardiomyopathy, Central nervous system cancer, Glioblastoma, Glioma, Insomnia, Meniere disease, Metabolic syndrome, Obesity, Substance abuse, Diabetes mellitus type 2 |
4848
|
|
|
Formyl peptide receptor 1 |
FMLP, FPR |
|
4849
|
|
|
Formyl peptide receptor 2 |
ALX, ALXR, FMLP-R-II, FMLPX, FPR2A, FPRH1, FPRH2, FPRL1, HM63, LXA4R |
|
4850
|
|
|
Formyl peptide receptor 3 |
FML2_HUMAN, FMLP-R-II, FMLPY, FPRH1, FPRH2, FPRL2, RMLP-R-I |
|